Tocilizumab for painful chronic pancreatitis
Treatments studied
Part of Digestive system clinical trials.
This study tests if a drug called tocilizumab can reduce pain from chronic pancreatitis. It works by calming inflammation. You may qualify if you have had recent flare-ups and don't have other serious health issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chronic pancreatitis (diagnosed by a doctor using scans, tests, or biopsy).
- You have had at least one episode of worsening pancreatic pain in the last 6 months, with signs of inflammation.
- Your pancreas is not severely shrunken (based on imaging).
- You have had no alcohol or drug abuse for the past 6 months (small amounts of alcohol are allowed).
- You do not have active infections, stomach ulcers that are untreated, or certain blood problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how “inflammation” in the pancreas changes over time—going from a first or repeated attack to long-term (chronic) pancreatitis. It may help doctors understand what drives progression and identify people at higher risk for chronic disease.
This trial tests if tocilizumab can help people with chronic pain from CPPD crystal arthritis (also called pseudogout). It is for people whose pain has not responded to usual treatments like colchicine, NSAIDs, or steroids.
This trial tests whether pirfenidone, an oral medication that may reduce scarring and inflammation, can help relieve pain in people with chronic pancreatitis. If you have ongoing pain or frequent flare-ups, this study could offer a new treatment option.
This Phase 1 study tests a new cell-based treatment to reduce pain caused by chronic pancreatitis. It’s designed mainly to check safety first, and it may help people with ongoing, opioid-stable pancreatic pain.
This trial tests whether a new treatment using stem cells can safely reduce long-term pain from chronic pancreatitis. It is for people who have had pancreatic pain for at least 6 months and are already taking daily pain medicine.
This study uses a special pain-testing method to better predict how people with chronic pancreatitis-related pain (or similar conditions) will respond to treatment. It may help doctors choose therapies that work better for each person’s type of pain.
Hear when a new Pancreatitis, Chronic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.